TipRanks
Advertisement
Advertisement

AQST Stock Latest News

Nano-X, Truist, Caesars, Aquestive, United Micro Shock
Weekend UpdatesNano-X, Truist, Caesars, Aquestive, United Micro Shock
13h ago
CZR
TFC
Analyst Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target Following Anaphylm NDA Resubmission
PremiumRatings
Analyst Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target Following Anaphylm NDA Resubmission
2d ago
AQST
Aquestive resubmits Anaphylm NDA, advancing allergy treatment
PremiumCompany Announcements
Aquestive resubmits Anaphylm NDA, advancing allergy treatment
3d ago
8K
AQST
Aquestive Therapeutics Earnings Call Highlights Anaphylm Progress
PremiumCompany Announcements
Aquestive Therapeutics Earnings Call Highlights Anaphylm Progress
1M ago
AQST
Aquestive Advances Anaphylm Program and Q2 2026 Results
PremiumCompany Announcements
Aquestive Advances Anaphylm Program and Q2 2026 Results
1M ago
8K
AQST
Aquestive Therapeutics reports Q2 EPS (18c), consensus (12c)
PremiumThe FlyAquestive Therapeutics reports Q2 EPS (18c), consensus (12c)
1M ago
AQST
Aquestive Therapeutics backs FY26 revenue view $46M-$50M, consensus $50.51M
Premium
The Fly
Aquestive Therapeutics backs FY26 revenue view $46M-$50M, consensus $50.51M
1M ago
AQST
Aquestive Therapeutics options imply 6.1% move in share price post-earnings
Premium
The Fly
Aquestive Therapeutics options imply 6.1% move in share price post-earnings
1M ago
AQST
Aquestive Advances Anaphylm With Positive Study Results
PremiumCompany Announcements
Aquestive Advances Anaphylm With Positive Study Results
1M ago
8K
AQST
Aquestive Therapeutics, Inc. (AQST) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Aquestive Therapeutics, Inc. (AQST) Q2 Earnings Cheat Sheet
1M ago
AQST
Aquestive Therapeutics files to sell 230,271 shares of common stock for holders
PremiumThe Fly
Aquestive Therapeutics files to sell 230,271 shares of common stock for holders
3M ago
AQST
BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm
PremiumRatings
BTIG’s Brisebois Reiterates Buy on Aquestive Therapeutics, Calling Sell-Off Overdone After SPRY Payer Update and Highlighting Limited Scope of FDA CRL for Anaphylm
3M ago
AQST
Aquestive Shareholders Back Directors, Pay Plan, Auditor
PremiumCompany AnnouncementsAquestive Shareholders Back Directors, Pay Plan, Auditor
3M ago
8K
AQST
Aquestive Therapeutics Charts Cautious, Liquid Path Forward
Premium
Company Announcements
Aquestive Therapeutics Charts Cautious, Liquid Path Forward
4M ago
AQST
Aquestive Therapeutics Signals Momentum In Earnings Call
Premium
Company Announcements
Aquestive Therapeutics Signals Momentum In Earnings Call
4M ago
AQST
Midday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
PremiumThe Fly
Midday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
4M ago
AEM
FNV
Aquestive Secures New Oaktree Term Loan to Fund Anaphylm
PremiumCompany Announcements
Aquestive Secures New Oaktree Term Loan to Fund Anaphylm
4M ago
8K
AQST
Aquestive Therapeutics reports Q1 EPS (7c), consensus (13c)
PremiumThe Fly
Aquestive Therapeutics reports Q1 EPS (7c), consensus (13c)
4M ago
AQST
Aquestive Therapeutics options imply 7.1% move in share price post-earnings
PremiumThe Fly
Aquestive Therapeutics options imply 7.1% move in share price post-earnings
4M ago
AQST
AQST Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsAQST Upcoming Earnings Report: What to Expect?
4M ago
AQST
Aquestive Therapeutics assumed with an Outperform at Oppenheimer
Premium
The Fly
Aquestive Therapeutics assumed with an Outperform at Oppenheimer
5M ago
AQST
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
Premium
Market News
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
5M ago
AQST

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >